Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Bimatoprost is safe and effective for improving eyebrow hair.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Certain drugs, especially those for eyes, bacterial infections, imaging tests, and skin conditions, are more likely to cause itching, with differences seen across gender, age, and weight.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

Choose between topical and oral minoxidil for hair growth based on personal tolerance and side effects.

New treatments for hair loss are being developed using molecular biology.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Finasteride can help with hair loss but may cause mental health issues like depression and anxiety.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.